The management of multimorphic cancer pain is a major supportive care in oncology, for which many national and international recommendations have recently been updated. Any cancer patient must benefit from access to supportive care from the diagnosis, throughout the entire care pathway. Chronic renal failure, from any etiology, requires special attention and constant attention to details from interdisciplinary caregivers' teams to propose the best analgesic therapeutic strategy, combining complementary and interventional approaches to treatments. Analgesic therapies, in particular opioids and antineuropathics, require specific precautions. A therapeutic alliance integrating clinical pharmacy as a supportive care in its own right, is a major asset allowing the optimization and securing of analgesic drug treatments, conditioning both their efficacy, their tolerance and therapeutic observance, in the goal of improving the patient's quality of life.
Keywords: Chronic renal failure; Clinical pharmacy; Douleur multimorphe du cancer; Insuffisance rénale chronique; Multimorphic cancer pain; Pharmacie clinique; Soins de support; Supportive care.
Copyright © 2023 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.